biomedicina slovenica

re="Breast" : 83

  1. Templeton Arnoud; Ocaña Alberto; Šeruga Boštjan; Vera-Badillo Francisco; Carlsson Lindsay; Bedard Philippe L.; Amir Eitan
    Management of small HER2 overexpressing tumours
    2012 ►
  2. Vardy JL; Pond Gregory Russell; Dodd Anna; Warr David; Šeruga Boštjan; Clemons Mark J; Bordeleau Louise; Goodwin Peter C; Tannock Ian
    A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer
    2012 ►
  3. Merlo Domenico Franco; Primic-Žakelj Maja
    Breast cancer incidence trends in European women aged 20-39 years at diagnosis
    2012 ►
  4. Ahčan Uroš; Bračun Drago; Živec Katarina; Pavlič Rok; Butala Peter
    The use of 3D laser imaging and a new breast replica cast as a method to optimize autologous breast reconstruction after mastectomy
    2012 ►
  5. Krajc Mateja
    Epidemiology of breast cancer and management of BRCA + patiens
    2012 ►
  6. Marolt-Mušič Maja
    Breast anatomy
    2012 ►
  7. Hertl Kristijana
    BI-RADS: breast imaging reporting and data system
    2012 ►
  8. Marolt-Mušič Maja
    US of axilla
    2012 ►
  9. Kadivec Maksimiljan; Hertl Kristijana
    Intervention procedures in breast and non-palpable breast lesions localizations
    2012 ►
  10. Žgajnar Janez
    Breast symptoms: clinical point of view and what surgeon needs to know
    2012 ►
  11. Hertl Kristijana
    Postsurgical breast imaging
    2012 ►
  12. Borštnar Simona
    Systemic treatment of breast cancer
    2012 ►
  13. Marinko Tanja
    Radiotherapy in breast cancer treatment
    2012 ►
  14. Kadivec Maksimiljan; Hertl Kristijana
    Screening in Slovenia: where are we now
    2012 ►
  15. Cardoso F; Costa A; Norton L; Cameron D; Čufer T; Fallowfield L; Francis P; Gligorov J; Kyriakides S; Lin N
    1st International consensus guidelines for advanced breast cancer (ABC 1)
    2012 ►
  16. Regan MM; Price KN; Giobbie-Hurder A; Thuerliman B; Gelber RD; Čufer T; Pajk B; Červek J
    Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    2011 ►
  17. Čufer Tanja; Vrdoljak Eduard; Gaafar Rabab; Erensoy Inci; Pomberton Kristine
    Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer
    2010 ►
  18. Čufer Tanja
    Barriers and challenges for academic cancer research
    2010 ►
  19. Čufer Tanja
    Translation research on new molecular markers: an EORTC BCG experinece
    2010 ►
  20. Šeruga Boštjan; Amir Eitan
    Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis
    2010 ►
  21. Borštnar Simona; Sadikov Aleksander; Možina Barbara; Čufer Tanja
    High levels of uPA and PAI-1 predict a good response to anthracyclines
    2010 ►
  22. Španinger K; Matos E; Možina B; Borštnar S; Sytkowski AJ; Komel R; Debeljak N
    Isoelectric focusing: method for detection of total erythropoietin in urine and plasma in cancer patients
    2010 ►
  23. But Hadžić Jasna; Bilban-Jakopin Cvetka; Hadžić Vedran
    The role of radiation therapy in locally advanced breast cancer
    2010 ►
  24. Perhavec Andrež; Pohar-Perme Maja; Hočevar Marko; Bešić Nikola; Žgajnar Janez
    Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
    2010 ►
  25. Bešić Nikola; Kramarič Anja; Podnar Blaže; Perhavec Andraž; Marolt-Mušič Maja; Frković-Grazio Snježana; Žgajnar Janez
    Factors correlated to successful surgical treatment of 181 non-palpable invasive breast carcinomas
    2009 ►
  26. Korde Larissa A; Lusa Lara; McShane Lisa; Lebowitz Peter F; Lukes LuAnne; Camphausen Kevin; Parker Joel S; Swain Sandra M; Hunter Kent; Zujewski Jo Anne
    Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    2009 ►
  27. Snoj Nataša; Bedard Philippe L.; De Azambuja Evandro; Cardoso Fatima; Piccart Martine
    Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
    2009 ►
  28. Golouh R; Čufer T; Sadikov A; Nussdorfer P; Usher PA; Brunner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
    The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
    2008 ►
  29. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009 ►
  30. Zhang Yi; Sieuwerts Anieta M; McGreevy Michelle; Casey Graham; Čufer Tanja; Paradiso Angelo; Harbeck Nadia; Span Paul N; Hicks David G; Golouh Rastko
    The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
    2009 ►
  31. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009 ►
  32. Ortmann Olaf; Čufer Tanja; Dixon J Michael; Maass Nicolai; Marchetti Paolo; Pagani Olivia; Pronzato Paolo; Semiglazov Vladimir; Spano Jean-Philippe; Vrdoljak Eduard; Wildiers Hans
    Adjuvant endocrine therapy for perimenopausal women with early breast cancer
    2009 ►
  33. Snoj N; Čufer T
    Two faces of screen detected cancers
    2009 ►
  34. Ravnik M; Sadikov A; Snoj N; Nussdorfer P; Čufer T
    Validation of Adjuvant online on Slovenian collective of hormone receptor (HR) positive early breast cancer patients
    2009 ►
  35. Karina M; Čufer Tanja
    Preliminary safety data of the EORTC 10994/BIG 00-01 neoadjuvant trial comparing 3 cycles of docetaxel followed by 3 cycles of epirubicin-docetaxel versus 6 cycles of FEC 100 in patients with locally advanced/inflammatory or large operable breast cancer
    2006 ►
  36. Golouh Rastko; Čufer Tanja; Sadikov A; Nusdorfer P; Usher P; Bruenner N; Schmitt M; Harbeck N; Lesche R; Meier S
    Stathmin-1 protein expression is associated with disease recurrence in tamoxifen-treated steroid hormone receptor positive early breast cancer: an immunohistochemical study
    2006 ►
  37. Žgajnar J
    Breast conserving surgery
    2003 ►
  38. Žgajnar Janez
    Surgical management of nonpalpable breast lesions
    2003 ►
  39. Čufer Tanja; Borštnar Simona; Vrhovec Ivan
    Prognostic and predictive value of the urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in operable breast cancer
    2003 ►
  40. Reberšek Martina; Čufer Tanja; Serša Gregor
    Electrochemotherapy (ECT) with intratumoral application of cisplatin in breast cancer
    2003 ►
  41. Južnič-Šetina Tanja; Čufer Tanja; Borštnar Simona
    Breast cancer in men: a 20 year review of 60 patients in Slovenia
    2003 ►
  42. Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
    Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
    2008 ►
  43. Berne S; Španinger K; Komel R; Debeljak N
    Molecular mechanism of recombinant human erythropoietin action on cancer cells
    2008 ►
  44. Feldman Laurie; Jeong Jee-Yeong; Davis Kerry L; Socha Amanda L; Španinger Klemen; Sytkowski Arthur
    Role of the erythropoietin receptor in breast cancer pathobiology
    2008 ►
  45. Debrakeleer S.; De Greve Jacques; Krajc Mateja; Sermijn E.; Fontaine C.; Goelen Guido; Bonduelle M.; Novaković Srdjan; Teugels Erik
    Germline mutation of the BARD1 ankyrin domain in a non-BRCA1/2 breast cancer family
    2006 ►
  46. Žgajnar Janez
    Digital evaluation of breast cosmesis after breast-conserving treatment: end of the beginning
    2007 ►
  47. Žgajnar Janez; Hočevar Marko; Podkrajšek Maja; Hertl Kristijana; Frković-Grazio Snježana; Vidmar Gaj; Bešić Nikola
    Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early patients
    2006 ►
  48. Čufer Tanja
    Chemotherapy in the adjuvant setting: goals and strategies
    2005 ►
  49. Piccart MJ; de Valeriola D; Dal-Lago L; de Azambuja E; Demonty G; Lebrun F; Bernard-Marty Ch; Colozza M; Čufer T
    Adjuvant chemotherapy in 2005: standards and beyond
    2005 ►
  50. Žgajnar Janez
    Sentinel lymphnode biopsy - from clinical trial to practice
    2005 ►
  51. Čufer Tanja
    Palliative and supportive care
    2005 ►
  52. Primic-Žakelj Maja
    Epidemiology of breast cancer: incidence and mortality trends, prevention and control
    2005 ►
  53. Čufer T; Piccart-Gebhart M
    Adjuvant chemotherapy: standards and beyond
    2005 ►
  54. Borštnar S; Vrhovec I; Čufer T
    High levels of uPA and PAI-1 predicts a good response to antracyclines
    2004 ►
  55. Juretič Antonio; Kavalar Rajko; Spagnoli Guilio C; Šarčevič Božena; Terracciano Luigi
    Immunohistochemical detection of melanoma antigen E (MAGE) expression in breast carcinoma
    2004 ►
  56. Snoj Marko
    Application of surgical gamma probe: the principles and practice
    2003 ►
  57. Lamovec J; Wotherspoon A; Jacquemier J
    Malignant lymphoma and metastatic tumours
    2003 ►
  58. Žgajnar J; Bešić N; Hočevar M; Vidergar B; Hertl K; Frković-Grazio S
    Radioguided occult lesions localisation (ROLL) of the nonpalpable breast lesions using reduced dose (1,8 MBq) of radioactivity
    2003 ►
  59. Žgajnar Janez
    DCIS general strategy - multidisciplinary approach
    2003 ►
  60. Paridaens R; Dirix L; Beex L; Nooij MN; Čufer T; Lohrisch C; Biganzoli L; van Hoorebeeck I; Duchateau L; Lobelle JP; Piccart M
    Promising results with exemestane in the first-line treatment of metastatic breast cancer: a randomized phase II EORTC trial with a tamoxifen control
    2000 ►
  61. Čufer Tanja
    Palliative and supportive care
    2003 ►
  62. Žgajnar Janez
    Sentinel lymphnode biopsy - from clinical trial to practice
    2003 ►
  63. Primic-Žakelj Maja
    Epidemiology of breast cancer
    2003 ►
  64. Cauley Jane A; Norton Larry; Lippman Marc E; Eckert Stephen; Krueger Kathryn A; Purdie David W; Farrerons Jordi; Karasik Avraham; Mellstrom Dan; Kocijančič Andreja
    Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
    2001 ►
  65. Snoj Marko
    Application of surgical gamma probe: the principles and practice
    2001 ►
  66. Snoj Marko
    Application of surgical gamma probe: the principles and practice
    2002 ►
  67. Borštnar S; Vrhovec I; Svetič B; Čufer T
    Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients
    2002 ►
  68. Bonnefoi H; Biganzoli L; Čufer T; Mauriac L; Hamilton A; Schaefer P; Picart M
    An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer
    2001 ►
  69. Primic-Žakelj Maja
    Epidemiology of breast cancer in the XXI century
    2001 ►
  70. Thuerlimann B; Price KN; Castiglione M; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International breast cancer study group trial 11-93
    2001 ►
  71. Bonetti M; Gelber RD; Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Cerar O; Šebek S; Novak J; Naglas M; Senčar M; Červek J; Čufer T
    Features that predict responsiveness to chemotherapy and endocrine therapies
    2001 ►
  72. Robertson C; van den Donk M; Primic-Žakelj M; MacFarlane T; Boyle P
    The association between induced and spontaneous abortion and risk of breast cancer in Slovenian women aged 25-54
    2001 ►
  73. Rakar S; Rainer S; Kovačič J
    Experience with serous papillary tumors of the ovary
    1983 ►
  74. Kos L
    Surgical treatment of recurrent cervical cancer
    1983 ►
  75. Rainer S
    Cervical carcinoma stage I. (Score for treatment)
    1983 ►
  76. Čavič M; Rakar S; Kovačič J
    Analysis of treatment failures in stage I and stage II carcinoma of the cervix
    1983 ►
  77. Kovačič J
    Surgical management and integrated therapies in invasive cervical cancer
    1983 ►
  78. Uršič-Vrščaj Marjetka
    Hormone replacement therapy in women with a history of breast cancer
    1999 ►
  79. Levičar N; Blejec A; Kos J; Golouh R; Vrhovec I; Frkovič-Gracio S; Lah TT
    Prognostic impact of serine and cysteine proteinases and their inhibitors in breast carcinoma
    1999 ►
  80. Bonnefoi H; Biganzoli L; Čufer T; Hamilton A; Mauriac L; Van Hoorebeeck I; Piccart M
    A feasibility study of epirubicin (E) in combination with cyclophosphamide (C) and infusional 5-fluorouracil (F-infu)(CEF-infu) as primary treatment of large operable (LO) or locally advanced/inflammatory (LA/I) breast cancer (BC)
    1999 ►
  81. Lah TT; Čerček M; Kos J; Lowder J; Gorodetsky E; Daskal I
    Epidermal growth factor receptor (EGFR), Her-2
    1996 ►
  82. Lah Tamara T; Calaf Gloria; Kalman Endre; Shinde Balasahib G; Somers Robert; Estrada Sandino; Salero Enrique; Russo Jose; Daskal Ierachmiel
    Cathepsins D, B, and L in transformed breast epithelial cells
    1996 ►
  83. Vlaisavljević V
    Comparison of ultrasonographic diagnosis and cytologic analysis of cyst aspirates
    1991 ►

Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko